[
    [
        {
            "time": "2020-01-16",
            "original_text": "孙飘扬卸任恒瑞医药董事长，周云曙接任 恒瑞医药回应：正常人事变动 董监高成员变化",
            "features": {
                "keywords": [
                    "孙飘扬",
                    "卸任",
                    "恒瑞医药",
                    "董事长",
                    "周云曙",
                    "接任",
                    "人事变动"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "孙飘扬卸任恒瑞医药董事长，周云曙接任 恒瑞医药回应：正常人事变动 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-01-17",
            "original_text": "沃森生物(300142)：2019年来累涨52%，13价肺炎疫苗将带来多大想象力？",
            "features": {
                "keywords": [
                    "沃森生物",
                    "2019年",
                    "累涨",
                    "52%",
                    "13价肺炎疫苗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物(300142)：2019年来累涨52%，13价肺炎疫苗将带来多大想象力？",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-01-17",
            "original_text": "广东潮金刘跃：5G时代的到来，可能是手机产业链要出现反转的时候",
            "features": {
                "keywords": [
                    "5G",
                    "手机产业链",
                    "反转"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "广东潮金刘跃：5G时代的到来，可能是手机产业链要出现反转的时候",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-01-17",
            "original_text": "营收、净利均大涨逾30%，超3600亿元市值的恒瑞却首提要“合规转型”，释放了什么信号？",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "营收",
                    "净利",
                    "上涨",
                    "合规转型"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "营收、净利均大涨逾30%，超3600亿元市值的恒瑞却首提要“合规转型”，释放了什么信号？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-01-17",
            "original_text": "北向资金净流入1.75亿美的集团成昨日大赢家",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流入",
                    "美的集团"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金净流入1.75亿美的集团成昨日大赢家",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]